Immunocore Holdings PLC
NASDAQ:IMCR

Watchlist Manager
Immunocore Holdings PLC Logo
Immunocore Holdings PLC
NASDAQ:IMCR
Watchlist
Price: 34.17 USD 1.24%
Market Cap: 1.7B USD
Have any thoughts about
Immunocore Holdings PLC?
Write Note

Immunocore Holdings PLC
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immunocore Holdings PLC
Operating Expenses Peer Comparison

Comparables:
CNTA
EXAI
AUTL
BCYC
GNS

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Immunocore Holdings PLC
NASDAQ:IMCR
Operating Expenses
-ÂŁ308m
CAGR 3-Years
-37%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Operating Expenses
-$178.1m
CAGR 3-Years
-157%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Operating Expenses
-ÂŁ167.1m
CAGR 3-Years
-91%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Operating Expenses
-$177.2m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Operating Expenses
-$233.4m
CAGR 3-Years
-45%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Operating Expenses
-ÂŁ614.6m
CAGR 3-Years
-6%
CAGR 5-Years
-36%
CAGR 10-Years
-6%

See Also

What is Immunocore Holdings PLC's Operating Expenses?
Operating Expenses
-308m GBP

Based on the financial report for Dec 31, 2023, Immunocore Holdings PLC's Operating Expenses amounts to -308m GBP.

What is Immunocore Holdings PLC's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-21%

Over the last year, the Operating Expenses growth was -67%. The average annual Operating Expenses growth rates for Immunocore Holdings PLC have been -37% over the past three years , -21% over the past five years .

Back to Top